AlphaStocks

AZN vs TER

ASTRAZENECA PLC vs TERADYNE, INC — Side-by-Side Stock Comparison

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$184.80

TER

TERADYNE, INC

6.8

Consider Buy

$382.39

AZN vs TER: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 8.4/10 while TERADYNE, INC (TER) scores 6.8/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy. On a P/E basis, ASTRAZENECA PLC trades at 28.2x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricAZNTER
Scores & Fundamentals
Composite Score8.4/106.8/10
RatingStrong BuyConsider Buy
Price$184.80$382.39
P/E Ratio28.2110.2
ROE21.9%20.1%
Market Cap$289B$60B
Fair Value$192.63
Dividend Yield1.7%
Sector Rank#2 of 1126#100 of 1126
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongAttractive
GrahamCautionNeutral
LynchNeutralNeutral
GreenblattNeutralCaution
View full AZNanalysis →View full TERanalysis →
Compare any two stocks →

AZN vs TER: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) and TERADYNE, INC (TER) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to TER's 6.8/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer